drugset / Trial / NCT02338830
Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix
RandomizedParallel-groupOpen-labelPrevention
Summary
To evaluate the value of vaginal progesterone therapy for reduction of preterm labor in asymptomatic twin pregnancies who have sonographic short cervix
Timeline
- Start
- 2012-06
- Primary completion
- 2014-10
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Progesterone | Other / unclassified | 400 mg | Other |
Indications
No indication recorded.